# Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System

> **NCT07653295** · — · RECRUITING · sponsor: **TIPMED Medical Device Manufacturing Ltd. Co.** · enrollment: 35 (estimated)

## Conditions studied

- Revision Hip Arthroplasty
- Aseptic Loosening of Prosthetic Joint
- Prostheses-related Infections
- Joint Instability
- Periprosthetic Fractures
- Prosthesis Failure

## Interventions

- **DEVICE:** Tıpmed™ Revision Hip Prosthesis System

## Key facts

- **NCT ID:** NCT07653295
- **Lead sponsor:** TIPMED Medical Device Manufacturing Ltd. Co.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-12
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07653295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07653295, "Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07653295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*